United Therapeutics Corp. (UTHR)
541.70
-29.68
(-5.19%)
USD |
NASDAQ |
Oct 02, 16:00
537.12
-4.58
(-0.85%)
After-Hours: 20:00
United Therapeutics Gross Profit Margin (Quarterly) : 87.30% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 87.30% |
| March 31, 2026 | 82.93% |
| December 31, 2025 | 86.91% |
| September 30, 2025 | 87.38% |
| June 30, 2025 | 89.03% |
| March 31, 2025 | 88.36% |
| December 31, 2024 | 89.69% |
| September 30, 2024 | 88.90% |
| June 30, 2024 | 89.12% |
| March 31, 2024 | 89.24% |
| December 31, 2023 | 88.45% |
| September 30, 2023 | 88.50% |
| June 30, 2023 | 89.25% |
| March 31, 2023 | 89.68% |
| December 31, 2022 | 88.04% |
| September 30, 2022 | 92.79% |
| June 30, 2022 | 93.64% |
| March 31, 2022 | 94.39% |
| December 31, 2021 | 91.67% |
| September 30, 2021 | 93.77% |
| June 30, 2021 | 91.67% |
| March 31, 2021 | 93.93% |
| December 31, 2020 | 90.96% |
| September 30, 2020 | 93.69% |
| June 30, 2020 | 92.85% |
| Date | Value |
|---|---|
| March 31, 2020 | 93.43% |
| December 31, 2019 | 90.74% |
| September 30, 2019 | 91.78% |
| June 30, 2019 | 92.85% |
| March 31, 2019 | 91.97% |
| December 31, 2018 | 91.64% |
| September 30, 2018 | 87.42% |
| June 30, 2018 | 86.12% |
| March 31, 2018 | 86.33% |
| December 31, 2017 | 88.59% |
| September 30, 2017 | 95.62% |
| June 30, 2017 | 95.75% |
| March 31, 2017 | 96.14% |
| December 31, 2016 | 93.06% |
| September 30, 2016 | 94.22% |
| June 30, 2016 | 95.15% |
| March 31, 2016 | 99.81% |
| December 31, 2015 | 93.75% |
| September 30, 2015 | 97.15% |
| June 30, 2015 | 95.37% |
| March 31, 2015 | 93.66% |
| December 31, 2014 | 95.45% |
| September 30, 2014 | 87.63% |
| June 30, 2014 | 88.01% |
| March 31, 2014 | 89.43% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Liquidia Corp. | 93.10% |
| MannKind Corp. | 69.00% |
| Insmed, Inc. | 83.71% |
| Alnylam Pharmaceuticals, Inc. | 76.88% |
| Savara, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 19.77% |
| Return on Assets | 17.64% |
| Return on Invested Capital | 19.77% |
| Profit Margin (Quarterly) | 42.51% |
| Operating Margin (Quarterly) | 42.23% |
| Return on Net Operating Assets | 56.78% |